Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Other Operating Expenses (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Other Operating Expenses for 3 consecutive years, with $72328.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 150.46% to $72328.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $315171.0 through Dec 2025, up 317.57% year-over-year, with the annual reading at $315171.0 for FY2025, 317.57% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $72328.0 at BioScience Health Innovations, down from $130357.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $130357.0 in Q3 2025, with the low at $9850.0 in Q1 2024.
  • Average Other Operating Expenses over 3 years is $49042.5, with a median of $32332.0 recorded in 2024.
  • The sharpest move saw Other Operating Expenses crashed 89.03% in 2024, then skyrocketed 468.15% in 2025.
  • Over 3 years, Other Operating Expenses stood at $9950.0 in 2023, then surged by 190.23% to $28878.0 in 2024, then soared by 150.46% to $72328.0 in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $72328.0, $130357.0, and $76700.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.